Skip to main content
SpringerLink
Log in

Systematic review: adverse events with Janus kinase inhibitors

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Olivera P, et al. Safety of Janus Kinase Inhibitors in Patients with Inflammatory Bowel Diseases or Other Immune-mediated Diseases: a Systematic Review and Meta-Analysis. Gastroenterology : 8 Jan 2020. Available from: URL: http://doi.org/10.1053/j.gastro.2020.01.001

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Systematic review: adverse events with Janus kinase inhibitors. Reactions Weekly 1788, 11 (2020). https://doi.org/10.1007/s40278-020-74134-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-74134-8

Search

Navigation